Meropenem Dosing for XDR Typhoid in a 50 kg Child
For a 50 kg child with extensively drug-resistant (XDR) typhoid, administer meropenem 1 gram (20 mg/kg) intravenously every 8 hours as a prolonged infusion over 3 hours, for a total duration of 10-14 days.
Rationale for This Recommendation
FDA-Approved Pediatric Dosing
According to the FDA label, for pediatric patients weighing over 50 kg with complicated intra-abdominal infections (which includes severe systemic infections like typhoid), the standard dose is 1 gram every 8 hours 1. Since your patient is exactly 50 kg, this adult-equivalent dosing applies.
Why Standard Dosing May Be Insufficient for XDR Typhoid
The evidence strongly suggests that standard meropenem dosing often fails to achieve adequate pharmacokinetic/pharmacodynamic (PK/PD) targets in children, particularly against resistant organisms:
- Only 41.3% of children weighing >50 kg achieve therapeutic targets for organisms with MIC of 2 mg/L using standard dosing, and only 17% achieve targets for MIC of 4 mg/L 2
- Current dosing recommendations fail to meet therapeutic targets in an "unacceptable fraction" of pediatric patients over 3 months of age 2
Optimized Dosing Strategy
Extended infusion is critical. Meropenem exhibits time-dependent killing, with efficacy correlating to the percentage of time the free drug concentration remains above the pathogen's MIC (%fT>MIC) 3. For XDR organisms:
- Administer as a 3-hour extended infusion rather than the standard 15-30 minute infusion 4, 5
- This approach significantly improves PK/PD target attainment without increasing toxicity
- High-dose extended infusion meropenem showed 81.6% clinical response and 81.1% microbiological response in critically ill children with highly resistant gram-negatives 4
Clinical Evidence in Typhoid
Recent data confirms meropenem's effectiveness against resistant Salmonella typhi:
- Meropenem demonstrated 94.32% sensitivity against S. typhi isolates in a large pediatric cohort 6
- Case reports document successful treatment of ceftriaxone-resistant, MDR typhoid with meropenem, including rapid clinical improvement within 48 hours 7, 8
- A 14-day course proved effective and safe even in pregnancy 7
Practical Implementation
Dosing specifics:
- Dose: 1 gram (or 20 mg/kg if weight <50 kg)
- Frequency: Every 8 hours
- Infusion time: 3 hours (not the standard 30 minutes)
- Duration: 10-14 days minimum
- Route: Intravenous only
Monitoring:
- Clinical response should occur within 48-72 hours
- Consider therapeutic drug monitoring if available, targeting trough concentrations >8 mg/L 5
- Monitor renal function, as this is the primary factor affecting meropenem levels 5
Important Caveats
Renal function adjustment: If creatinine clearance is <50 mL/min, reduce dosing frequency to every 12 hours 1. However, this is uncommon in otherwise healthy children with typhoid.
Alternative if meropenem unavailable: Based on WHO guidelines, ceftriaxone 80 mg/kg daily (maximum 4 grams) remains an option for standard MDR typhoid 9, but XDR strains are typically ceftriaxone-resistant, making meropenem essential.
Combination therapy is not recommended for meropenem-susceptible organisms 10, 11. Monotherapy is appropriate when the organism is confirmed susceptible to meropenem.
Do not use fluoroquinolones as first-line therapy given the high resistance rates (60-73% resistance to ciprofloxacin in recent studies) 6, 8.